Current Research Studies

A PHASE 3, RANDOMIZED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS

Beatrix_GBS_C1091009

Phase: III
Clinicaltrials.gov ID: NCT07160244

What is the goal of the study?

Study to Evaluate the Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Janet Englund
Study Team Member: Jamie Costales, [email protected]